Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
gDCA for postprandial metabolic responses in healthy men and men with type 2 diabetes
NL-OMON20316Phase 2Recruiting
- Sponsor
- Academic Medical Center
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of glycodeoxycholic acid and ezetimibe in type 2 diabetes mellitus (T2DM), sponsored by Academic Medical Center. Started Jun 2018; status: recruiting.
02
Drugs
glycodeoxycholic acidezetimibe
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON20316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20316.